Our newspaper, Beijing, March 9 (Reporter Xu Xinxing) "Chaos in medical and health advertising has always existed. Over the years, rectification actions have been carried out in various places, but the effectiveness still needs to be improved. Management of medical and health programs and pharmaceutical advertisements should be strengthened , severely punish false propaganda and standardize market order." Representative Xia Li, a senior technician at China Electronics Network Communications Research Institute, told reporters today.
This year's government work report proposed optimizing the consumption environment and implementing the "Safe Consumption Action", which triggered heated discussions among representatives.
This year’s National Two Sessions, Representative Xia Li submitted suggestions for strengthening the management of medical and health programs and pharmaceutical advertising.
To deal with the chaos in medical advertising, we need to "block the back door" and "open the front door."
Representative Ma Yongping, deputy director of the Second Hospital of Baoding City, Hebei Province, said: “We should encourage the diversification of medical information dissemination, and use the professionalism of medical workers and pharmaceutical companies and the enthusiasm of the mass media to disseminate scientific medical and health information to the public. At the same time, we will fully unleash market efficiency and carry out classified management of medical and health information and medical advertising."
"Currently, urban and rural residents still lack health knowledge and skills in rational use of drugs and disease prevention." Representative Ma Yongping believes that comprehensive and scientific medical and health information is the key to improving residents' health literacy and basic skills.
Health science publicity should be increased to alleviate the problems caused by medical information asymmetry.
In terms of advertising, we encourage innovative drugs to be promoted comprehensively, scientifically, objectively, and fairly after they are launched on the market, so that the results of innovative drugs can truly be exposed to the market and the public.
Xu Xinxing